PTBP1 as a Promising Predictor of Poor Prognosis by Regulating Cell Proliferation, Immunosuppression, and Drug Sensitivity in SARC.

Gong H, Jiang A, Jiang R, Wang Y, Zhang D, Wu Z, Xiao J

Open source

DOI
10.1155/2022/5687238
Published
2022
Container
Oxidative medicine and cellular longevity
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/5687238,
  title = {PTBP1 as a Promising Predictor of Poor Prognosis by Regulating Cell Proliferation, Immunosuppression, and Drug Sensitivity in SARC.},
  author = {Gong H and Jiang A and Jiang R and Wang Y and Zhang D and Wu Z and Xiao J},
  year = {2022},
  journal = {Oxidative medicine and cellular longevity},
  doi = {10.1155/2022/5687238},
  url = {https://doi.org/10.1155/2022/5687238}
}

RIS

TY  - JOUR
TI  - PTBP1 as a Promising Predictor of Poor Prognosis by Regulating Cell Proliferation, Immunosuppression, and Drug Sensitivity in SARC.
AU  - Gong H
AU  - Jiang A
AU  - Jiang R
AU  - Wang Y
AU  - Zhang D
AU  - Wu Z
AU  - Xiao J
PY  - 2022
JO  - Oxidative medicine and cellular longevity
DO  - 10.1155/2022/5687238
UR  - https://doi.org/10.1155/2022/5687238
ER  - 

APA

H, G., A, J., R, J., Y, W., D, Z., Z, W., & J, X. (2022). PTBP1 as a Promising Predictor of Poor Prognosis by Regulating Cell Proliferation, Immunosuppression, and Drug Sensitivity in SARC.. Oxidative medicine and cellular longevity. https://doi.org/10.1155/2022/5687238

Source records